Chargement en cours...

Beyond PD-1: The Next Frontier for Immunotherapy in Melanoma

The advent of first and second-generation immune checkpoint blockade (ICI) has resulted in improved survival of patients with metastatic melanoma over the past decade. However, the majority of patients ultimately progress despite these treatments, which has served as an impetus to consider a range o...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Oncol
Auteurs principaux: Rohatgi, Anjali, Kirkwood, John M.
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2021
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7958874/
https://ncbi.nlm.nih.gov/pubmed/33732652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.640314
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!